Rafael Holdings, Inc. (RFL)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 21, 2025

$2.07

P/E Ratio

N/A

Market Cap

$51.08M

Jan 25, 2024Feb 29, 2024Apr 3, 2024May 6, 2024Jun 10, 2024Jul 16, 2024Aug 19, 2024Sep 24, 2024Oct 29, 2024Dec 3, 2024Jan 21, 2025$0.00$10.00
  • CGA
Description

Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. It operates through the Healthcare, Infusion Technology and Real Estate segments. The Healthcare segment relates to the activities of LipoMedix, Barer, Farber, and Rafael Medical Devices. The company was founded in 2017 and is headquartered in Newark, NJ.

Metrics

Overview

  • HQNewark, NJ
  • SectorFinance
  • IndustryReal Estate Development
  • TickerRFL
  • Price$2.07+2.99%

Trading Information

  • Market cap$51.08M
  • Float75.44%
  • Average Daily Volume (1m)42,280
  • Average Daily Volume (3m)31,912
  • EPS-$1.67

Company

  • Revenue$0.70M
  • Rev growth (1yr)88.24%
  • Net income-$9.01M
  • Gross margin3.91%
  • EBITDA margin-2,935.94%
  • EBITDA-$3.76M
  • EV-$3.52M
  • EV/Revenue-5.06
  • P/EN/A
  • P/S71.46
  • P/B0.69
Documents